Cargando…
IGFBP-rP1 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer
Epithelial–mesenchymal transition (EMT) was initially recognized during organogenesis and has recently been reported to be involved in promoting cancer invasion and metastasis. Cooperation of transforming growth factor-β (TGF-β) and other signaling pathways, such as Ras and Wnt, is essential to indu...
Autores principales: | Zhu, S, Zhang, J, Xu, F, Xu, E, Ruan, W, Ma, Y, Huang, Q, Lai, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385937/ https://www.ncbi.nlm.nih.gov/pubmed/25789970 http://dx.doi.org/10.1038/cddis.2015.59 |
Ejemplares similares
-
IGFBP-rP1, a potential molecule associated with colon cancer differentiation
por: Ruan, Wenjing, et al.
Publicado: (2010) -
Downregulated IGFBP7 facilitates liver metastasis by modulating epithelial-mesenchymal transition in colon cancer
por: Li, Yuanfei, et al.
Publicado: (2019) -
miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis
por: Liu, Yankun, et al.
Publicado: (2017) -
MiR-1-3p Suppresses Colorectal Cancer Cell Proliferation and Metastasis by Inhibiting YWHAZ-Mediated Epithelial–Mesenchymal Transition
por: Du, Guanghong, et al.
Publicado: (2021) -
CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia
(ALL)
por: Vorwerk, P, et al.
Publicado: (2000)